Live birth following laparoscopic fertility-sparing surgery for papillary thyroid carcinoma arising from mature ovarian cystic teratoma: A case report.

Papillary thyroid carcinoma arising from ovarian mature cystic teratoma is clinically rare. We herein present a case of live birth following two laparoscopic surgeries for papillary thyroid carcinoma arising in a mature ovarian cystic teratoma. A 30-year-old female patient, gravida 1 para 1, was treated by laparoscopic bilateral ovarian cystectomy for suspicion of bilateral mature cystic teratoma. The diagnosis of papillary thyroid carcinoma arising from right ovarian mature cystic teratoma was established based on postoperative pathological examination of the tumor. Such rare neoplasms may be difficult to diagnose preoperatively based on radiological examinations alone. The patient underwent laparoscopic fertility-preserving unilateral (right) salpingo-oophorectomy. Following an extensive discussion with the patient and her family, appropriate informed consent was obtained for the treatment option and the patient and her family chose to preserve her fertility. She could have a baby following the treatment and no evidence of disease for 6 years. Gynecologists should be aware of the possibility of such rare cases, and the available surgical interventions should be fully discussed with patients who wish to preserve their fertility. Laparoscopic fertility-sparing surgery may be a feasible option when encountering such a rare condition.

Introduction

Mature cystic teratoma is a common neoplasm accounting for 10–20% of all ovarian tumors, and most of ovarian mature cystic teratomas occur in women of reproductive age (1). Although mature cystic teratoma is benign, malignant transformation occurs in ~1–2% of all cases, often in postmenopausal women with large tumors (2). The lack of characteristic symptoms and specific imaging findings may lead to preoperative misdiagnosis. Although preoperative diagnosis of mature cystic teratoma of the ovary is usually achieved with the use of sonography, computed tomography (CT) and magnetic resonance imaging (MRI), due to the detection of teeth, bones and cartilage (3), malignant transformation of mature cystic teratoma is usually detected incidentally postoperatively based on detailed pathological examination (4). The optimal treatment for malignant transformation of mature cystic teratoma is uncertain due to the rarity of the disease (5).

The most common malignant tumor in mature cystic teratomas is squamous cell carcinoma, whereas papillary thyroid carcinoma arising from mature cystic teratoma is extremely rare (6), with only 11 such cases documented in the English literature to date (5,7–16). In the majority of the cases, malignant transformation is diagnosed on postoperative pathological examination. Only 5 cases of papillary thyroid carcinoma arising from mature cystic teratoma have been reported in younger patients who wished to preserve their fertility (5,7–10), and the optimal clinical management strategy is not always clear due to our limited experience with such cases.

We herein report a rare case of live birth following two laparoscopic surgeries for papillary thyroid carcinoma arising from mature ovarian cystic teratoma. The patient was of reproductive age and the effects of surgical options on fertility were fully discussed when considering treatment.

Case report

A 30-year-old female patient, gravida 1 para 1, who had her first transvaginal delivery 1 month earlier, was referred to the Department of Obstetrics and Gynecology (Hashimoto Municipal Hospital, Wakayama, Japan) in April 2011 for a routine gynecological examination. Transvaginal ultrasound examination revealed bilateral cystic ovarian tumors, sized 2.7 cm on the right and 3.2 cm on the left side, which contained high-echogenicity regions. The tumor size grew to 4.2 cm on the right and 6.1 cm on the left side over the next 3 months. A CT scan revealed bilateral ovarian tumors with a partial solid component and calcification, without pelvic lymph node enlargement (Fig. 1). MRI could not be performed, as the patient had a cardiac pacemaker. Based on the imaging findings, the suspected diagnosis was bilateral ovarian teratoma. The results of the laboratory tests revealed normal levels of carbohydrate antigen (CA) 125 and carcinoembryonic antigen, and an elevated CA19-9 level to 70.0 U/ml (normal level ~37.0 U/ml). The serum biochemical examination and coagulation profile were within normal limits. The serum level of thyroid-stimulating hormone was also within normal limits. Laparoscopic bilateral cystectomy was performed. An intraoperative examination revealed bilateral ovarian cystic tumors, which were mobile and had a smooth surface, both of which were enucleated; there were no adhesions or invasion of other organs (Fig. 2A and B). The tumors were placed in a plastic bag and ruptured, and the contents of the bag were aspirated and removed through the umbilical trocar site. No free fluid was detected in the peritoneal cavity. No frozen sections were prepared for pathological examination.

Figure 1.

Computed tomography findings of papillary thyroid carcinoma arising in a mature cystic ovarian teratoma (arrowheads, right ovary; arrows, left ovary).

Figure 2.

Laparoscopic and macroscopic findings of papillary thyroid carcinoma arising in a mature cystic teratoma. (A) Left ovarian tumor on the first surgery. (B) Right ovarian tumor on the first surgery. (C) Macroscopic appearance of the resected tumors. (D) Right ovary on the second surgery.

Macroscopically, the bilateral cystic ovarian tumors exhibited the typical structure of dermoid cysts containing hair and fat (Fig. 2C). Microscopically, the left tumor was a mature cystic teratoma containing hair follicles, adipose, bone, cartilaginous and brain tissue, whereas the right tumor was a mature cystic teratoma with a thyroid gland component displaying papillary structure (Fig. 3). The tumor cells had oval or round overlapping nuclei with a ground glass appearance. Immunohistochemical examination revealed positive staining of the tumor cells for cytokeratin (CK) 19, and Hector Battifora mesothelial epitope-1 (HBME-1). The diagnosis of papillary thyroid carcinoma arising from ovarian mature cystic teratoma was confirmed based on the pathological findings.

Figure 3.

Microscopic findings of papillary thyroid carcinoma arising in a mature cystic teratoma. Hematoxylin and eosin staining; magnification (A) ×40 and (B) ×200.

In order to exclude distant metastasis, positron emission tomography (PET)-CT was performed. PET-CT revealed normal thyroid, lung, liver, pancreas, spleen, kidneys and retroperitoneal space. No enlarged lymph nodes were identified in the intra-abdominal and retroperitoneal space. The surgical options were fully discussed with the patient, in order to decide whether to perform right unilateral salpingo-oophorectomy or complete surgery for ovarian cancer (total abdominal hysterectomy, bilateral salpingo-oophorectomy, omentectomy, pelvic lymphadenectomy and para-aortic lymphadenectomy), and she opted for unilateral salpingo-oophorectomy to preserve her fertility. One month after the first laparoscopic surgery, laparoscopic right unilateral salpingo-oophorectomy was performed. No free fluid was detected in the peritoneal cavity, and the peritoneal lavage cytology was negative. The right ovary was normal in size, without adhesions or obvious invasion of other organ (Fig. 2D). On histopathological examination, the right ovary was free from cancer infiltration. Adjuvant chemotherapy was not administered and the patient gave birth following natural conception without any problems 2 years following surgery. There was no evidence of local recurrence or systemic disease in September 2017.

Discussion

The majority of mature cystic teratomas are composed of well-differentiated derivatives of the three germ layers, namely the ectoderm, the mesoderm and the endoderm, while ectodermal elements usually predominate, and it has been reported that ~15% of the tumors contain thyroid tissue (6). The complications of mature cystic teratoma include torsion (16%), malignant degeneration (2%), rupture (1–2%) and infection (1%) (17), whereas uncomplicated teratomas are found incidentally on routine gynecological examination in asymptomatic patients. The main concern with treating mature cystic teratoma is the possibility of malignant transformation, which can only be correctly diagnosed postoperatively based on detailed pathological examination. Particularly in women of reproductive age, malignant transformation of mature cystic teratoma is even more uncommon. The survival outcome of patients with malignant transformation of mature cystic teratoma depends on the stage at diagnosis.

Papillary thyroid cancer arising from mature cystic teratoma is a rare occurrence, with an estimated incidence of 0.1–0.3% (18), with 11 cases in total reported in the literature to date (5,7–16), among which only 5 were patients of reproductive age (5,7–10) according to a search of the English literature on PubMed and MEDLINE. In patients of reproductive age, including the case in the present study (5,7–10), the mean age and tumor size were 29.2 years (range, 19–39 years) and 8.62 cm (range, 4.2–15 cm), respectively. In two cases the patients were asymptomatic and the tumors were discovered incidentally (5,10). To the best of our knowledge, the tumor in the present case was the smallest among all reported asymptomatic cases of reproductive age, indicating that the size of the tumor and the presence of symptoms are not indicative of the diagnosis.

The most appropriate clinical management strategy for papillary thyroid carcinoma arising from mature cystic teratoma is not always clear, as our experience with such cases is limited. Laparoscopic surgery is usually selected when the gynecologist suspects mature cystic teratoma, as it is a minimally invasive surgery, and it may also be possible to treat patients wishing to preserve their fertility by fertility-sparing surgery including unilateral salpingo-oophorectomy or cystectomy without adjuvant chemotherapy. According to previous reports on the condition, abdominal cystectomy was performed in 2 cases (7,8), laparoscopic salpingo-oophorectomy in 1 case (5), laparoscopic salpingo-oophorectomy followed by total abdominal hysterectomy with contralateral salpingo-oophorectomy in 1 case (9), and abdominal cystectomy followed by abdominal adnexectomy in 1 case (10). The long-term prognosis of papillary thyroid carcinoma arising from mature cystic teratoma is unclear, with a limited number of reports on follow-up time (6–33 months). The prognosis appears to be favorable, as no metastasis or recurrence have been reported. In the present case, laparoscopic bilateral cystectomy was first performed, followed by unilateral salpingo-oophorectomy. The options were fully discussed with the patient and their family and written informed consent was obtained. The patient was advised that she would be able to become pregnant following treatment, provided there was no evidence of disease for 6 years. To improve the treatment of papillary thyroid carcinoma arising from mature cystic teratoma in the future, further data regarding its natural history, diagnosis and treatment outcome are needed.

In summary, we herein present a rare case of papillary thyroid carcinoma arising from a mature cystic ovarian teratoma, in which two laparoscopic surgeries was performed and the patient was able to successfully carry a pregnancy to term after treatment. Gynecologists should be aware of the possibility of such rare cases, and the available surgical interventions should be fully discussed with patients who wish to preserve their fertility. Laparoscopic fertility-sparing surgery may be a viable treatment option when encountering such rare cases.